Following several recent studies questioning the safety of popular testosterone replacement therapy (TRT) drugs, The FDA last month announced it will open a new investigation into heart attack, stroke and death risks.
In just four years, three different studies have questioned the safety of TRTs for older male patients and those with a history of heart problems. However, the news has gone unheeded in a booming industry until now.
Within a decade, the use of low-T drugs has grown by five-fold, to the current level of 5.5 million patients and nearly $2 billion in sales. Reports also suggest many of the prescriptions though, may be for men who don’t qualify.
The FDA approved testosterone drugs like AndroGel, Axiron and AndroDerm only for documented cases of low testosterone levels. Gainful manufacturers, however, have marketed them for many symptoms which they claim “could” be signs of low-T, including stress, fatigue or decreased sexual vitality. As many as 43% of those filling prescriptions already had normal testosterone levels, a study showed.
In November, a study of more than 8,000 VA patients taking TRTs discovered those over 65 or with a history of heart disease were 29% more likely to suffer a heart attack, stroke or death.
Last month, researchers at UCLA found men over 65 or with prior heart problems taking TRTs were twice as likely to suffer a heart attack.
Interestingly, a recent study also showed so-called research funded by pharmaceutical companies are less likely to uncover cardiac risks from testosterone drugs than independent studies.
Experts fear thousands of men may have suffered heart attacks or stroke since companies didn’t properly warn of the risks. Lawyers also say victims are entitled to compensation and have already begun investigating cases.
If you or a loved one suffered a heart attack or stroke after taking a low-T drug like AndroGel, Axiron or AndroDerm, talk with a lawyer soon about your legal options.
Cases are likely to be consolidated into a special court due to the volume of patients and the time to file a claim will be limited. However, it costs nothing to speak with a lawyer or file a claim.
DrugRisk only recommends lawyers who have already handled testosterone heart attack or stroke lawsuits.
For more information on the research, side effects and litigation news related to testosterone drugs, or to speak with a lawyer, contact us today.